Clinical Trial Update: The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update for Aleeto in an early-phase safety and preliminary efficacy study in patients with Multiple System Atrophy. Status: recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• Aleeto

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Multiple System Atrophy - Parkinsonian Subtype (MSA-P), Multiple System Atrophy, MSA | EARLY_Phase 1 | Status: RECRUITING